JLS Fund 1 LP
Follow-ons onlyEmerging manager
Follow-ons only: first sale Mar 2021, per Form D (fund age approximates vintage)
- Vintage
- 2021
- Fund size
- $5.26M to $50M (Form D)
- Stages
- Not stated
- Sectors
- Biotech, Healthtech
- Regions
- Not stated
01 · Thesis
No thesis found on the firm's website yet.
02 · Initial check
$53K to $833K (estimated from fund size)
Estimated from Form D: $5.26M sold of a $50M target
03 · Who to approach
Named on this fund's Form D
- Jeffrey Siegel, Partner & Investor Relations
- Lindsay Hoover, Managing partner
- Simeon Schnapper, Managing partner
- Michael Gruber, Managing Member of the Issuer's General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideWe finance and help build companies that translate breakthroughs in neuroscience, technology, and data into outcomes for patients—and value for strategic acquirers.
We finance and help build companies that translate breakthroughs in neuroscience, technology, and data into outcomes for patients—and value for strategic acquirers.
https://www.jls.fund/
06 · Sources
Last verified: Oct 28, 2026